FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approval of a supplemental application for TOBI Podhaler (tobramycin) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBI Podhaler (tobramycin inhalation powder)

Snippet

SUPPL AP for TOBI PODHALER (TOBRAMYCIN)